ClinicalTrials.Veeva

Menu

The Role of Noncontrast Computed Tomography Markers in Predicting the Clinical Outcome of Cerebral Hemorrhage

J

Jin Hu

Status

Not yet enrolling

Conditions

Intracerebral Hemorrhage

Study type

Observational

Funder types

Other

Identifiers

NCT06535438
FDHS2024

Details and patient eligibility

About

The goal of this observational study is to To investigate the ability of Noncontrast Computed Tomography to predict clinical prognosis in Intracerebral Hemorrhage.

The main question it aims to answer is:How to judge the prognosis of patients with cerebral hemorrhage by CT image reading at admission.

Enrollment

1,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age≥18 years
  2. had completed a CT examination within 24 h of disease onset;
  3. had a hemorrhage that was located in the brain parenchyma, including the basal ganglia, thalamus,brain lobes, brainstem, and cerebellum.

Exclusion criteria

  1. had secondary ICH caused by brain trauma,cerebrovascular malformations, aneurysms, and tumors;
  2. had ischemic cerebral infarction hemorrhagic transformation;
  3. had undergone surgical treatment (e.g.hematoma removal or puncture drainage) before the CT examination;
  4. had images of poor quality that could notbe accurately evaluated;
  5. had a hematoma withborders that could not be delineated, thus precluding delineation of the region of interest (ROI).

Trial design

1,000 participants in 2 patient groups

The prognosis of cerebral hemorrhage is good at 90 days
The prognosis of cerebral hemorrhage is poor at 90 days

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems